nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—Euphoric mood—Fluorouracil—colon cancer	0.0326	0.0326	CcSEcCtD
Phenylpropanolamine—Urinary retention—Vincristine—colon cancer	0.0281	0.0281	CcSEcCtD
Phenylpropanolamine—Ataxia—Vincristine—colon cancer	0.0278	0.0278	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Capecitabine—colon cancer	0.027	0.027	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Capecitabine—colon cancer	0.0265	0.0265	CcSEcCtD
Phenylpropanolamine—Irritability—Fluorouracil—colon cancer	0.0263	0.0263	CcSEcCtD
Phenylpropanolamine—Ataxia—Fluorouracil—colon cancer	0.0259	0.0259	CcSEcCtD
Phenylpropanolamine—Hallucination—Vincristine—colon cancer	0.0203	0.0203	CcSEcCtD
Phenylpropanolamine—Flushing—Irinotecan—colon cancer	0.0185	0.0185	CcSEcCtD
Phenylpropanolamine—Irritability—Capecitabine—colon cancer	0.0184	0.0184	CcSEcCtD
Phenylpropanolamine—Urinary retention—Capecitabine—colon cancer	0.0183	0.0183	CcSEcCtD
Phenylpropanolamine—Ataxia—Capecitabine—colon cancer	0.0181	0.0181	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Irinotecan—colon cancer	0.0178	0.0178	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Fluorouracil—colon cancer	0.017	0.017	CcSEcCtD
Phenylpropanolamine—Agitation—Vincristine—colon cancer	0.0164	0.0164	CcSEcCtD
Phenylpropanolamine—Vision blurred—Fluorouracil—colon cancer	0.0156	0.0156	CcSEcCtD
Phenylpropanolamine—Confusional state—Irinotecan—colon cancer	0.0143	0.0143	CcSEcCtD
Phenylpropanolamine—Irritability—Methotrexate—colon cancer	0.0137	0.0137	CcSEcCtD
Phenylpropanolamine—Confusional state—Fluorouracil—colon cancer	0.0137	0.0137	CcSEcCtD
Phenylpropanolamine—Hypotension—Vincristine—colon cancer	0.0136	0.0136	CcSEcCtD
Phenylpropanolamine—Ataxia—Methotrexate—colon cancer	0.0135	0.0135	CcSEcCtD
Phenylpropanolamine—Tachycardia—Fluorouracil—colon cancer	0.0132	0.0132	CcSEcCtD
Phenylpropanolamine—Hypotension—Irinotecan—colon cancer	0.0132	0.0132	CcSEcCtD
Phenylpropanolamine—Insomnia—Vincristine—colon cancer	0.0131	0.0131	CcSEcCtD
Phenylpropanolamine—Insomnia—Irinotecan—colon cancer	0.0128	0.0128	CcSEcCtD
Phenylpropanolamine—Hypotension—Fluorouracil—colon cancer	0.0127	0.0127	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Irinotecan—colon cancer	0.0126	0.0126	CcSEcCtD
Phenylpropanolamine—Somnolence—Irinotecan—colon cancer	0.0126	0.0126	CcSEcCtD
Phenylpropanolamine—Constipation—Vincristine—colon cancer	0.0124	0.0124	CcSEcCtD
Phenylpropanolamine—Flushing—Capecitabine—colon cancer	0.0124	0.0124	CcSEcCtD
Phenylpropanolamine—Insomnia—Fluorouracil—colon cancer	0.0123	0.0123	CcSEcCtD
Phenylpropanolamine—Constipation—Irinotecan—colon cancer	0.0121	0.0121	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Fluorouracil—colon cancer	0.0121	0.0121	CcSEcCtD
Phenylpropanolamine—Somnolence—Fluorouracil—colon cancer	0.012	0.012	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Capecitabine—colon cancer	0.0119	0.0119	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Irinotecan—colon cancer	0.0117	0.0117	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Fluorouracil—colon cancer	0.0112	0.0112	CcSEcCtD
Phenylpropanolamine—Drowsiness—Methotrexate—colon cancer	0.0111	0.0111	CcSEcCtD
Phenylpropanolamine—Vision blurred—Capecitabine—colon cancer	0.0109	0.0109	CcSEcCtD
Phenylpropanolamine—Tremor—Capecitabine—colon cancer	0.0109	0.0109	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Vincristine—colon cancer	0.0107	0.0107	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Irinotecan—colon cancer	0.0104	0.0104	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Fluorouracil—colon cancer	0.00998	0.00998	CcSEcCtD
Phenylpropanolamine—Anxiety—Capecitabine—colon cancer	0.00984	0.00984	CcSEcCtD
Phenylpropanolamine—Dizziness—Vincristine—colon cancer	0.00961	0.00961	CcSEcCtD
Phenylpropanolamine—Confusional state—Capecitabine—colon cancer	0.00955	0.00955	CcSEcCtD
Phenylpropanolamine—Dizziness—Irinotecan—colon cancer	0.00936	0.00936	CcSEcCtD
Phenylpropanolamine—Tachycardia—Capecitabine—colon cancer	0.00924	0.00924	CcSEcCtD
Phenylpropanolamine—Vomiting—Vincristine—colon cancer	0.00924	0.00924	CcSEcCtD
Phenylpropanolamine—Rash—Vincristine—colon cancer	0.00916	0.00916	CcSEcCtD
Phenylpropanolamine—Dermatitis—Vincristine—colon cancer	0.00915	0.00915	CcSEcCtD
Phenylpropanolamine—Vomiting—Irinotecan—colon cancer	0.009	0.009	CcSEcCtD
Phenylpropanolamine—Dizziness—Fluorouracil—colon cancer	0.00896	0.00896	CcSEcCtD
Phenylpropanolamine—Rash—Irinotecan—colon cancer	0.00892	0.00892	CcSEcCtD
Phenylpropanolamine—Dermatitis—Irinotecan—colon cancer	0.00891	0.00891	CcSEcCtD
Phenylpropanolamine—Hypotension—Capecitabine—colon cancer	0.00885	0.00885	CcSEcCtD
Phenylpropanolamine—Nausea—Vincristine—colon cancer	0.00863	0.00863	CcSEcCtD
Phenylpropanolamine—Vomiting—Fluorouracil—colon cancer	0.00862	0.00862	CcSEcCtD
Phenylpropanolamine—Insomnia—Capecitabine—colon cancer	0.00856	0.00856	CcSEcCtD
Phenylpropanolamine—Rash—Fluorouracil—colon cancer	0.00854	0.00854	CcSEcCtD
Phenylpropanolamine—Dermatitis—Fluorouracil—colon cancer	0.00854	0.00854	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Capecitabine—colon cancer	0.00844	0.00844	CcSEcCtD
Phenylpropanolamine—Nausea—Irinotecan—colon cancer	0.0084	0.0084	CcSEcCtD
Phenylpropanolamine—Vision blurred—Methotrexate—colon cancer	0.00814	0.00814	CcSEcCtD
Phenylpropanolamine—Constipation—Capecitabine—colon cancer	0.0081	0.0081	CcSEcCtD
Phenylpropanolamine—Nausea—Fluorouracil—colon cancer	0.00805	0.00805	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Capecitabine—colon cancer	0.0078	0.0078	CcSEcCtD
Phenylpropanolamine—Confusional state—Methotrexate—colon cancer	0.00711	0.00711	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Capecitabine—colon cancer	0.00698	0.00698	CcSEcCtD
Phenylpropanolamine—Hypotension—Methotrexate—colon cancer	0.00659	0.00659	CcSEcCtD
Phenylpropanolamine—Insomnia—Methotrexate—colon cancer	0.00638	0.00638	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Methotrexate—colon cancer	0.00628	0.00628	CcSEcCtD
Phenylpropanolamine—Somnolence—Methotrexate—colon cancer	0.00627	0.00627	CcSEcCtD
Phenylpropanolamine—Dizziness—Capecitabine—colon cancer	0.00626	0.00626	CcSEcCtD
Phenylpropanolamine—Vomiting—Capecitabine—colon cancer	0.00602	0.00602	CcSEcCtD
Phenylpropanolamine—Rash—Capecitabine—colon cancer	0.00597	0.00597	CcSEcCtD
Phenylpropanolamine—Dermatitis—Capecitabine—colon cancer	0.00597	0.00597	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methotrexate—colon cancer	0.00581	0.00581	CcSEcCtD
Phenylpropanolamine—Nausea—Capecitabine—colon cancer	0.00562	0.00562	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methotrexate—colon cancer	0.00519	0.00519	CcSEcCtD
Phenylpropanolamine—Dizziness—Methotrexate—colon cancer	0.00466	0.00466	CcSEcCtD
Phenylpropanolamine—Vomiting—Methotrexate—colon cancer	0.00448	0.00448	CcSEcCtD
Phenylpropanolamine—Rash—Methotrexate—colon cancer	0.00444	0.00444	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methotrexate—colon cancer	0.00444	0.00444	CcSEcCtD
Phenylpropanolamine—Nausea—Methotrexate—colon cancer	0.00419	0.00419	CcSEcCtD
